Pathology of intrahepatic cholangiocarcinoma.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 28261592)

Published in Hepatobiliary Surg Nutr on February 01, 2017

Authors

Sandrine Vijgen1, Benoit Terris2, Laura Rubbia-Brandt1

Author Affiliations

1: Division of Clinical Pathology, Geneva University Hospital and Faculty of Medicine of Geneva, Geneva, Switzerland.
2: Department of Histopathology, Paris Descartes University, Assistance Publique-Hôpitaux de Paris, Cochin University Hospital, Paris, France.

Articles cited by this

Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology (2006) 2.83

Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology (2012) 2.49

Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology (2008) 2.40

Intrahepatic cholangiocarcinoma with predominant "ductal plate malformation" pattern: a new subtype. Am J Surg Pathol (2012) 2.25

Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol (2006) 1.86

Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. Cancer Res (2010) 1.82

Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg (2003) 1.59

A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol (1988) 1.56

Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies. Oncogene (2013) 1.55

Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis (2011) 1.46

Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement. Pathol Int (2005) 1.26

Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol (2004) 1.04

Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer (2009) 1.01

Pathophysiology of the intrahepatic biliary epithelium. J Gastroenterol Hepatol (2000) 1.01

Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol (1999) 0.98

Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) (2015) 0.96

Functional anatomy of normal bile ducts. Anat Rec (Hoboken) (2008) 0.96

Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways. Carcinogenesis (2012) 0.95

Clinicopathological significance of S100 protein expression in cholangiocarcinoma. J Gastroenterol Hepatol (2013) 0.93

Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma. Eur J Surg Oncol (2014) 0.92

What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma? Int J Hepatol (2014) 0.92

Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. Semin Liver Dis (2011) 0.91

Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg (1999) 0.91

Cholangiocarcinoma: increasing burden of classifications. Hepatobiliary Surg Nutr (2013) 0.89

Cystic and micropapillary epithelial changes of peribiliary glands might represent a precursor lesion of biliary epithelial neoplasms. Virchows Arch (2014) 0.87

Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type. Am J Surg Pathol (2011) 0.85

Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan. Cancer (2015) 0.85

Histological features of precancerous and early cancerous lesions of biliary tract carcinoma. J Hepatobiliary Pancreat Sci (2014) 0.85

'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1. Histopathology (2005) 0.85

The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. Ann Surg Oncol (2014) 0.84

Latest advances in the pathological understanding of cholangiocarcinomas. Expert Rev Gastroenterol Hepatol (2015) 0.81

Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis. Virchows Arch (2010) 0.80

Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma. World J Gastrointest Pathophysiol (2014) 0.80

BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas. Am J Surg Pathol (2016) 0.80

Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma. Cancer Lett (2016) 0.79

Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion: a single-institution study with 184 patients. Surgery (2013) 0.79

Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia. Int J Hepatol (2014) 0.78

Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers. Hepatology (2016) 0.78

Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion. Hepatogastroenterology (2011) 0.77

Albumin expression distinguishes bile duct adenomas from metastatic adenocarcinoma. Histopathology (2016) 0.77

Adaptive remodeling of the biliary tree: the essence of liver progenitor cell expansion. J Hepatobiliary Pancreat Sci (2015) 0.77

BRAF V600E mutational status in bile duct adenomas and hamartomas. Histopathology (2015) 0.77